| Patents for C07K - Peptides (3,738) |
|---|
| 10/26/2000 | WO2000037646A3 Group b streptococcus proteins, and their use |
| 10/24/2000 | US6136783 Antifungal compositions |
| 10/19/2000 | CA2815763A1 Anti-bacterial vaccine compositions |
| 10/19/2000 | CA2815566A1 Pasteurellaceae bacteria comprising a mutated virulence gene and an anti-bacterial vaccine prepared therefrom |
| 10/18/2000 | CN1057534C Erythropoietin analogs |
| 10/17/2000 | US6133235 Glucagon-like insulinotropic peptides compositions and methods |
| 10/17/2000 | CA2178752C N-terminally chemically modified protein compositions and methods |
| 10/12/2000 | DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid |
| 09/20/2000 | EP0672057B1 Analogs of pth |
| 09/20/2000 | CN1267307A Interleukin-18 binding proteins, their preparation and use |
| 09/19/2000 | US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners |
| 09/13/2000 | EP1035127A1 Process for the preparation of N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorphenyl)-6-isopropylpyrimidin-2-yl]-N-methylmethansulfonamide |
| 09/12/2000 | US6117632 Detection of protein sequences which transfer compounds across human and animal tissues; incubation of phage with tissue, recover transported phage, amplify, repeat process with recovered phage, detect transport protein sequences |
| 08/30/2000 | EP1031628A1 Process for the production of protease inhibitors |
| 08/29/2000 | CA2010164C Anthracycline immunoconjugates having a novel linker and methods for their production |
| 08/22/2000 | US6107467 Process for purifying a compound |
| 08/15/2000 | US6103711 Inhibitors of interleukin-1β converting enzyme |
| 08/09/2000 | EP1025444A1 Determination of cellular growth abnormality |
| 08/09/2000 | EP1025125A1 Aggregates of human insulin derivatives |
| 08/08/2000 | CA2125376C Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/12/2000 | CN1259999A Human bikunin |
| 07/06/2000 | WO2000039156A1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 06/29/2000 | WO2000037646A2 Group b streptococcus proteins, and their use |
| 06/29/2000 | WO2000037490A2 Outer surface proteins, their genes, and their use |
| 06/29/2000 | CA2354843A1 Outer surface proteins, their genes, and their use |
| 06/29/2000 | CA2354135A1 Group b streptococcus proteins, and their use |
| 06/22/2000 | CA2405945A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2000 | WO2000034331A2 Analogues of glp-1 |
| 06/15/2000 | CA2778047A1 Analogues of glp-1 |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/13/2000 | US6075127 Adjusting polypeptide or peptide for efficient purification; inserting cleavable methionine and histidine tag at the end of polypeptide or peptide chain and preventing cleavage at interior methionine by the presence of sulfoxide groups |
| 06/08/2000 | WO2000032625A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 06/08/2000 | CA2352738A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 05/31/2000 | EP1003781A1 Interleukin-18 binding proteins, their preparation and use |
| 05/30/2000 | CA2063416C Methods of treating or preventing autoimmune uveoretinitis mammals |
| 05/25/2000 | WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 05/24/2000 | CN1052733C Immuno-stimulatory monoclonal antibodies |
| 05/23/2000 | US6066783 Genes encoding insecticidal proteins |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/16/2000 | CA2113660C Process for the obtention of biological adhesive made of concentrated coagulation factors by salting-out |
| 05/04/2000 | WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 05/03/2000 | EP0560947B1 Trivalent monospecific antigen binding proteins |
| 05/02/2000 | US6057133 Fusion protein associated with cell growth and regulation; for the activation of bone marrow propagation; for treatment of cancer, asthma and inflammation |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 04/26/2000 | EP0995755A1 Prodrugs of Thrombin inhibitors |
| 04/26/2000 | CN1251531A Treatment of inner ear hair cells |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/25/2000 | US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr. |
| 04/21/2000 | CA2286971A1 A method for the purification of natural phosphorylated peptides, a mixture of phosphopeptides thus obtained and the use thereof |
| 04/18/2000 | US6051554 Cyclized peptides |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/11/2000 | US6048898 Synthesis of glatiramer acetate (copolymer-1) |
| 04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
| 03/30/2000 | WO2000017369A2 Alzheimer's disease secretase |
| 03/30/2000 | WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 03/30/2000 | WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof |
| 03/30/2000 | CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 03/30/2000 | CA2343004A1 Alzheimer's disease secretase |
| 03/23/2000 | CA2341767A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/16/2000 | CA2341325A1 Method of stimulating prosaposin receptor activity |
| 03/14/2000 | US6037363 Respiratory system disorders, cystic fibrosis |
| 03/14/2000 | US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma |
| 03/08/2000 | EP0983361A1 Bacterial pheromones and uses therefor |
| 03/08/2000 | CN1246869A Novel human 'beta' 2 integrin 'alpha' subunit |
| 03/07/2000 | US6034215 3-amino-2-oxo-1-piperidnercetic derivatives as enzyme inhibitors |
| 02/29/2000 | US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| 02/24/2000 | WO2000009149A1 Tnf-derived peptides for use in treating oedema |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/22/2000 | CA1340906C Fibronectin binding protein as well as its preparation |
| 02/17/2000 | WO2000001815A3 Neurotrophic factors |
| 02/16/2000 | EP0979827A1 Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same |
| 02/15/2000 | US6025147 Inhibitors of interleukin-1 β converting enzyme |
| 02/08/2000 | US6022535 Administering human interleukin-3 variant or mutant proteins (muteins) fused with other colony stimulating factors, cytokines, lyphokines, interleukins, hematopoietic growth factors; treating side effects of cancer radiation therapy |
| 02/03/2000 | WO1999060120A3 Soluble t cell receptor |
| 02/03/2000 | WO1999060119A3 Multivalent t cell receptor complexes |
| 02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
| 01/18/2000 | CA2050336C Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/12/2000 | EP0970124A2 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 01/12/2000 | CN1240829A Optimization method for activation of endogenetic gene of cell |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 12/28/1999 | CA1340861C Cysteine-depleted muteins of biologically active proteins |
| 12/16/1999 | WO1999064462A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 12/14/1999 | US6001801 Administering antidiabetic agent cyclic peptide to inhibit insulin release in patient |
| 12/14/1999 | US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae |
| 12/14/1999 | CA1340847C Adhesin antigens |
| 12/09/1999 | WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 12/08/1999 | CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use |
| 11/25/1999 | WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 11/25/1999 | WO1999060120A2 Soluble t cell receptor |
| 11/25/1999 | WO1999060119A2 Multivalent t cell receptor complexes |
| 11/25/1999 | CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 11/25/1999 | CA2328144A1 Multivalent t cell receptor complexes |